The cost of Alzheimer's disease in China and re-estimation of costs worldwide
Recommended Citation
Jia J, Wei C, Chen S, Li F, Tang Y, Qin W, Zhao L, Jin H, Xu H, Wang F, Zhou A, Zuo X, Wu L, Han Y, Han Y, Huang L, Wang Q, Li D, Chu C, Shi L, Gong M, Du Y, Zhang J, Zhang J, Zhou C, Lv J, Lv Y, Xie H, Ji Y, Li F, Yu E, Luo B, Wang Y, Yang S, Qu Q, Guo Q, Liang F, Zhang J, Tan L, Shen L, Zhang K, Zhang J, Peng D, Tang M, Lv P, Fang B, Chu L, Jia L, and Gauthier S. The cost of Alzheimer's disease in China and re-estimation of costs worldwide. Alzheimers Dement 2018; 14(4):483-491.
Document Type
Article
Publication Date
4-1-2018
Publication Title
Alzheimers Dement
Abstract
INTRODUCTION: The socioeconomic costs of Alzheimer's disease (AD) in China and its impact on global economic burden remain uncertain.
METHODS: We collected data from 3098 patients with AD in 81 representative centers across China and estimated AD costs for individual patient and total patients in China in 2015. Based on this data, we re-estimated the worldwide costs of AD.
RESULTS: The annual socioeconomic cost per patient was US $19,144.36, and total costs were US $167.74 billion in 2015. The annual total costs are predicted to reach US $507.49 billion in 2030 and US $1.89 trillion in 2050. Based on our results, the global estimates of costs for dementia were US $957.56 billion in 2015, and will be US $2.54 trillion in 2030, and US $9.12 trillion in 2050, much more than the predictions by the World Alzheimer Report 2015.
DISCUSSION: China bears a heavy burden of AD costs, which greatly change the estimates of AD cost worldwide.
Medical Subject Headings
Aged; Aged, 80 and over; Alzheimer Disease; China; Cost of Illness; Cross-Sectional Studies; Female; Forecasting; Health Care Costs; Humans; Male; Middle Aged; Socioeconomic Factors
PubMed ID
29433981
Volume
14
Issue
4
First Page
483
Last Page
491
